Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma is a research paper published in Signal Transduction and Targeted Therapy (2024). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R35 CA197706
NCI NIH HHS
Grant: P30 CA016058
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
National Institutes of Health
Grant: 5R35CA197706-04
Cancer Gene Discovery to Identify Targetable Targets
FWCI
3.38
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC)
Additional file 1 of circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC)
Additional file 2 of circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC)
Additional file 2 of circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC)